Vascepa, a prescription omega-3 fatty acid, is effective in reducing heart disease risk. The medication reduces inflammation and has helped reduce major adverse cardiovascular events by 25% in patients with high triglycerides and established cardiovascular disease, according to the REDUCE-IT trial. Other studies also found Vascepa reduced the risk of cardiovascular events by 18%. The average cost of Vascepa is around $250 per month.
Threat Actors Exploiting DevOps Web Servers Misconfigurations To Deploy Malware
A new cryptojacking campaign, led by threat actor JINX-0132, exploits misconfigurations in popular DevOps applications like HashiCorp Nomad and Docker API. By utilizing legitimate tools
